- Home
- EW
as 09-16-2025 4:00pm EST
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
| Founded: | 1958 | Country: | United States |
| Employees: | N/A | City: | IRVINE |
| Market Cap: | 45.5B | IPO Year: | 2000 |
| Target Price: | $85.74 | AVG Volume (30 days): | 3.9M |
| Analyst Decision: | Buy | Number of Analysts: | 19 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 7.02 | EPS Growth: | 188.09 |
| 52 Week Low/High: | $64.00 - $83.00 | Next Earning Date: | 10-23-2025 |
| Revenue: | $5,685,100,000 | Revenue Growth: | 9.14% |
| Revenue Growth (this year): | 13.25% | Revenue Growth (next year): | 9.76% |
Stock Insider Trading Activity of Edwards Lifesciences Corporation (EW)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Chopra Daveen | EW | CVP, TMTT | Aug 25 '25 | Sell | $81.95 | 2,500 | $204,865.00 | 30,996 | |
| Wood Larry L | EW | Global President TAVR & Surg | Aug 18 '25 | Sell | $78.06 | 8,950 | $698,679.07 | 206,900.391 |
Latest Edwards Lifesciences Corporation News
EW Breaking Stock News: Dive into EW Ticker-Specific Updates for Smart Investing
Simply Wall St.
2 days ago
Institutional investors in Edwards Lifesciences Corporation (NYSE:EW) see US$1.5b decrease in market cap last week, although long-term gains have benefitted them.
Simply Wall St.
2 days ago
Undervalued Small Caps With Insider Buying In Global For September 2025
GlobeNewswire
7 days ago
Picard Announces Appointment of Two New Members to its Board of Directors
Insider Monkey
7 days ago
Edwards Lifesciences Corporation (EW) Welcomes Newly Updated ESC/EACTS Guidelines for Severe Aortic Stenosis (AS)
Medical Device Network
11 days ago
Edwards Lifesciences’ TAVR growth continues as global demand rises
Zacks
12 days ago
Top Stock Reports for Apple, Novartis & Charles Schwab
MedTech Dive
14 days ago
Edwards, Medtronic and Abbott stand to benefit from new TAVR guidelines in Europe
Insider Monkey
15 days ago
Leerink Partners Lifts Edwards Lifesciences (EW) Price Target Amid Buybacks Focus
Compare EW vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EW Edwards Lifesciences Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.